Hospital
Seminole Hma, LLC
Seminole Hma, LLC was paid $3.46M by Medicaid between Jan 2018 and Jun 2022, across 58 billing codes. Its largest line is 99283, emergency room visit (moderate) — 40% of everything it billed.
33Billing provider infoSEMINOLE HMA, LLC
SEMINOLE, OK 74868
SEMINOLE, OK 74868
33aNPI1891980124assigned 09/10/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.46M
24GClaims54,343
24DCodes billed58
24AFirst – last monthJan 2018 – Jun 2022
Compared with peers
Next to other General Acute Care Hospital providers in Oklahoma
Rank by total paid#40 of 75
Median peer was paid$3.66M
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,934 | $646K | |
| 2019 | 9,405 | $651K | |
| 2020 | 8,242 | $517K | |
| 2021 | 16,340 | $1.02M | |
| 2022 | 9,422 | $626K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 40% | 8,983 | 8,838 | $1.38M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 3,816 | 3,764 | $854K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.3% | 1,201 | 1,176 | $286K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.0% | 1,514 | 1,474 | $173K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.7% | 2,044 | 2,002 | $92K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.2% | 1,253 | 1,219 | $77K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.8% | 696 | 691 | $62K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.7% | 2,859 | 2,793 | $59K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.6% | 2,013 | 1,987 | $56K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.5% | 371 | 365 | $51K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.2% | 863 | 858 | $43K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 2,883 | 2,866 | $41K |
46 more codes
| 80053 | Comprehensive metabolic panel | 1.1% | 4,019 | $38K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 844 | $33K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 228 | $33K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,898 | $27K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,334 | $24K |
| 87428 | <1% | 377 | $21K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 221 | $15K |
| 87081 | <1% | 2,147 | $13K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,363 | $12K |
| 87430 | <1% | 804 | $12K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 139 | $8K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 161 | $7K |
| 87420 | <1% | 448 | $5K | |
| 97597 | <1% | 286 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 340 | $5K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 77 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 463 | $3K |
| 85027 | <1% | 350 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 123 | $2K |
| 83690 | <1% | 296 | $2K | |
| 84439 | <1% | 233 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 15 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 176 | $1K |
| 81001 | <1% | 512 | $1K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 20 | $1K |
| 81003 | <1% | 628 | $1K | |
| 81025 | <1% | 151 | $1K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 12 | $1K |
| 80061 | Lipid panel | <1% | 83 | $945.62 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 15 | $769.65 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 79 | $480.72 |
| 84484 | <1% | 25 | $321.98 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12 | $315.96 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 12 | $312.10 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 12 | $304.10 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 20 | $235.40 |
| 83655 | <1% | 14 | $172.20 | |
| 87040 | <1% | 12 | $161.85 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 234 | $101.04 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14 | $96.52 |
| 82550 | <1% | 12 | $69.48 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 26 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 119 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 25 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 451 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.